Clinical Trial Update: Intravenous Ganaxolone as Adjunctive Therapy to Treat Subjects With Status Epilepticus [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intravenous ganaxolone as adjunctive therapy for status epilepticus (completed; results posted).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Convulsive Status Epilepticus
• Epilepsy
• Non-convulsive Status Epilepticus
• Status Epilepticus

Drugs mentioned

• ganaxolone (ganaxolone)

Snippet

Sponsor: Marinus Pharmaceuticals | Conditions: Status Epilepticus, Convulsive Status EPILEPTICUS | Phase 2 | Status: COMPLETED | Results posted: 2022-12-15